Bill Gates is on a visit to China, his first since 2019, and on Thursday the Bill & Melinda Gates Foundation announced a $50 million investment in Beijing's Global Health Drug Discovery Institute.
GHDDI is China's first public-private partnership on innovative research, and its focus is on developing new drugs for communicable diseases such as tuberculosis and malaria, which disproportionately affect the world's poorest countries, per a press release.
The release notes that low- and middle-income countries account for 90% of the global burden of infectious diseases, but only 10% of the global spending on drug research and development goes toward diseases that disproportionately affect these populations.
"We hope GHDDI will continue to drive R&D breakthroughs, ultimately improving the availability and accessibility of drugs for those in need around the world," says Zheng Zhijie, Gates Foundation's China country director.
Read the Entire Article
A customized collection of news from foundations from around the Web.
Social entrepreneur, Stefan Wolf , founded the Beyond the Four Walls, which builds cyber “resource centers” (aka Internet cafes) in rural areas for young women to run.